![]() | Up a level |
Inngjerdingen, M.; Rabe, A.; Deen, D.; Stankova, Z.; Hirn, A.; Tischer, J.; Schmid, C.; Schmetzer, H. (2016): Immunemodulation of AML-blasts with clinically approved response modifiers improves antileukemic T-cell reactivity ex vivo and leads to blast-reduction in vivo (rat-Modell). In: Bone Marrow Transplantation, Vol. 51: S474-S474